Price
No data yet.
Social Signal Score
Analyst Ratings
15 analystsRevenue
$982.00M+58.64%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Sean D. Keohane
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 4,064
- Beta
- 0.83
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 3.20
Financials
Revenue
$982.00M+58.6%Net Income
$6.00M-88.5%EBITDA
$148.00M+24.4%Free Cash Flow
$37.00M-37.3%EPS (diluted)
$0.12-85.5%Shares Outstanding (diluted)
52.00M-17.3%Operating Expenses
$86.00MCash & Debt
$250.00MReturn of Capital
$24.00MRevenue by Segment (annual)
$3.59BDividend per Share
$0.47Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.71B | $331.00M | $6.07 |
| 2024 | $3.99B | $380.00M | $6.79 |
| 2023 | $3.93B | $445.00M | $7.79 |
| 2022 | $4.32B | $209.00M | $3.65 |
| 2021 | $3.41B | $250.00M | $4.36 |
| 2020 | $2.61B | $-238.00M | $-3.96 |
| 2019 | $3.34B | $157.00M | $2.67 |
| 2018 | $3.24B | $-113.00M | $-1.87 |
| 2017 | $2.72B | $241.00M | $3.89 |
| 2016 | $2.41B | $149.00M | $2.40 |
| 2015 | $2.87B | $-331.00M | $-5.30 |
| 2014 | $3.65B | $201.00M | $3.12 |
| 2013 | $3.46B | $155.00M | $2.42 |
| 2012 | $3.30B | $389.00M | $6.14 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CBT's reported EPS growth of -0.1% a year over 13 years.
- EPS in 5 years
- $6.13
- Implied price
- $79.73
- Return from $76.95
- 0.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $39.64 — -48.5% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 9 | 11 | 13 | 15 | 17 |
|---|---|---|---|---|---|
| -10.1% | -15.8% | -12.3% | -9.4% | -6.7% | -4.4% |
| -5.1% | -11.1% | -7.5% | -4.3% | -1.6% | 0.9% |
| -0.1% | -6.4% | -2.6% | 0.7% | 3.6% | 6.3% |
| 4.9% | -1.7% | 2.3% | 5.8% | 8.8% | 11.6% |
| 9.9% | 2.9% | 7.2% | 10.8% | 14.0% | 16.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
55-26.67%Social Signal Score
Mentions (12)
- Newszacks.com·23h ago·Neutral
Is Cabot (CBT) Outperforming Other Basic Materials Stocks This Year? Here is how Cabot (CBT) and Carpenter Technology (CRS) have performed compared to their sector so far this year.
View source ↗ - Newsgurufocus.com·13d ago·Positive
Cabot Corp (CBT) Stock Up 3.8% and Still Undervalued -- GF Score: 82/100 On September 22, 2026, Cabot Corp (CBT) shares rose 3.8% today, trading at $79.47. The stock has experienced a 52-week range between $58.33 and $94.53, reflecti
View source ↗ - Newszacks.com·17d ago·Neutral
Cabot Expands Battery Materials Platform With $50M DOE Grant CBT plans a two-site battery materials expansion, backed by a modified $50M DOE grant, to boost U.S. conductive additives output by 2028.
View source ↗ - Newsdefenseworld.net·18d ago·Negative
1,660,122 Shares in Cabot Corporation $CBT Purchased by Bank of America Corp DE Bank of America Corp DE purchased a new position in shares of Cabot Corporation (NYSE: CBT) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,660,122 shares of the specialty chemicals company's stock, valued at approximately $150,772,000.
View source ↗ - Newsglobenewswire.com·21d ago·Neutral
Cabot Corporation Appoints Steve Delahunt as Interim Chief Financial Officer BOSTON, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced that it has appointed Steve Delahunt, Vice President and Corporate Treasurer, to serve as Chief Financial Officer on an interim basis, effective October 1, 2026.
View source ↗ - News (RSS)forbes·21d ago·Neutral
Cabot Unveils New Golf Destination With Cabot Wilds In Nova Scotia Cabot unveils Cabot Wilds, a 2,500-acre Nova Scotia golf destination near its original home, developed in partnership with Canadian businessman John Bragg.
View source ↗ - Newszacks.com·26d ago·Neutral
Cabot Stock Rallies 17% in 6 Months: Here's What's Driving the Upside CBT shares climb 16.8% in six months as Battery Materials demand, capacity expansion and cost savings support growth and cash generation.
View source ↗ - Newszacks.com·33d ago·Neutral
Why Is Cabot (CBT) Down 1.6% Since Last Earnings Report? Cabot (CBT) reported earnings 30 days ago. What's next for the stock?
View source ↗ - Newszacks.com·33d ago·Negative
Reasons Why You Should Retain Cabot Stock in Your Portfolio Now CBT is riding battery-materials growth, circular products and capacity expansion, even as weaker pricing and rising costs pressure profitability.
View source ↗ - News (RSS)seekingalpha·54d ago·Neutral
Cabot Corporation prices $350M senior notes offering to refinance 2026 debt
View source ↗ - Newsglobenewswire.com·54d ago·Negative
Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029 BOSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced that it priced a public offering of $350 million of 4.950% senior unsecured notes due 2029. The notes are being sold to the public at a price of 99.993% of the face amount thereof.
View source ↗ - Newszacks.com·56d ago·Positive
CBT Q3 Earnings Beat Estimates on Performance Chemicals Strength Cabot's Q3 fiscal 2026 earnings beat estimates as Performance Chemicals gains offset Reinforcement Materials margin pressure.
View source ↗
Earnings
Mon, Nov 2(in 4 weeks)
Consensus estimate $1.55 per share
Typical surprise +2.2% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$1.67 vs $1.65beat
- Tue, May 5$1.61 vs $1.47beat
- Tue, Feb 3$1.53 vs $1.40beat
- Mon, Nov 3$1.70 vs $1.72miss
- Mon, Aug 4$1.90 vs $1.80beat
- Mon, May 5$1.90 vs $1.86beat
Estimates and results for CBT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CBT officers and directors.
- Bought
- —
- Sold
- $19.6m
0 trades
3 trades
- Keohane Sean Dsold
- Keohane Sean Dsold
- Keohane Sean Dsold
97 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Lois Frankelhouse · FL21 · disclosed Dec 20, 2019 (17d later)Sell$1,001 - $15,000
- Lois Frankelhouse · FL21 · disclosed Dec 20, 2019 (16d later)Sell$1,001 - $15,000
- Susan Margaret Collinssenate · ME · disclosed May 16, 2014 (9d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.